These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2115592)
1. Human chorionic gonadotropin and rat mammary cancer prevention. Russo IH; Koszalka M; Russo J J Natl Cancer Inst; 1990 Aug; 82(15):1286-9. PubMed ID: 2115592 [TBL] [Abstract][Full Text] [Related]
3. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Russo IH; Koszalka M; Russo J Carcinogenesis; 1990 Oct; 11(10):1849-55. PubMed ID: 2119909 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Russo IH; Koszalka M; Russo J Br J Cancer; 1991 Sep; 64(3):481-4. PubMed ID: 1911188 [TBL] [Abstract][Full Text] [Related]
5. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Srivastava P; Russo J; Russo IH Carcinogenesis; 1997 Sep; 18(9):1799-808. PubMed ID: 9328178 [TBL] [Abstract][Full Text] [Related]
6. Effect of human chorionic gonadotrophin on 7,12-dimethylbenz[a]anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Tay LK; Russo J Chem Biol Interact; 1985 Oct; 55(1-2):13-21. PubMed ID: 3933840 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Srivastava P; Russo J; Russo IH Mol Carcinog; 1999 Sep; 26(1):10-9. PubMed ID: 10487517 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Russo J; Russo IH Am J Pathol; 1980 Aug; 100(2):497-512. PubMed ID: 6773421 [TBL] [Abstract][Full Text] [Related]
9. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol. Russo IH; Frederick J; Russo J Breast Cancer Res Treat; 1989 Oct; 14(1):43-56. PubMed ID: 2513893 [TBL] [Abstract][Full Text] [Related]
10. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea. VanderPloeg LC; Wolfrom DM; Welsch CW Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195 [TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats. Yuri T; Lai YC; Yoshizawa K; Tsubura A In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interrelations among BHT concentration, carcinogen dose, and diet. Cohen LA; Choi K; Numoto S; Reddy M; Berke B; Weisburger JH J Natl Cancer Inst; 1986 Apr; 76(4):721-30. PubMed ID: 3083149 [TBL] [Abstract][Full Text] [Related]
13. Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland. Malejka-Giganti D; Bennett KK; Culp SJ; Beland FA; Shinozuka H; Bliss RL Cancer Detect Prev; 2005; 29(4):338-47. PubMed ID: 16054776 [TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats. Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209 [TBL] [Abstract][Full Text] [Related]
16. Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Russo IH; Gimotty P; Dupuis M; Russo J Br J Cancer; 1989 Feb; 59(2):210-6. PubMed ID: 2522791 [TBL] [Abstract][Full Text] [Related]
17. The plasticizer benzyl butyl phthalate (BBP) inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary DNA adduct formation and tumorigenesis. Singletary K; MacDonald C; Wallig M Carcinogenesis; 1997 Aug; 18(8):1669-73. PubMed ID: 9276647 [TBL] [Abstract][Full Text] [Related]
18. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. Tanaka H; Hirose M; Kawabe M; Sano M; Takesada Y; Hagiwara A; Shirai T Cancer Lett; 1997 Jun; 116(1):47-52. PubMed ID: 9177457 [TBL] [Abstract][Full Text] [Related]
19. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer. Thun-Battersby S; Mevissen M; Löscher W Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973 [TBL] [Abstract][Full Text] [Related]
20. Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. De Jonage-Canonico MB; Lenoir V; Martin A; Scholler R; Kerdelhué B Breast Cancer Res Treat; 2003 Jun; 79(3):365-77. PubMed ID: 12846421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]